Webinar on Demand

Uncovering Novel Modulators of PLCγ2 in Alzheimer’s Research with CETSA®

We are pleased to present our on-demand webinar, “How CETSA® has been applied in Lead Generation delivering novel modulators of PLCγ2,” featuring Fiona Jeganathan, Head of Pharmacology and Screening at the Alzheimer’s Research UK UCL Drug Discovery Institute

In this insightful session, you will learn about:

  • Innovative Applications of CETSA: Discover how our CETSA technology is utilized to identify novel PLCγ2 modulators for Alzheimer’s disease, providing new avenues for therapeutic development.
  • Advanced Lead Generation Strategies: Gain insights into cutting-edge approaches in drug discovery that enhance the identification and development of potential drug candidates.
  • Expert Perspectives: Benefit from Fiona Jeganathan’s extensive experience in pharmacology and screening, as she shares valuable knowledge on advancing research in this critical field.

This webinar is designed for professionals in drug discovery, pharmacology, and related fields interested in the latest methodologies and applications of CETSA® in lead generation.

Check below for more information about our services:

Our services

We offer a wide range of services, from Target Discovery to Preclinical Studies.